MDT and patient perspectives on the role of GLP-1 RAs in the T2D management pathway

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient explore the role of GLP-1 RAs in the T2D management pathway, real-world factors affecting selection of a GLP-1 RA, and how GLP-1 RA therapy has influenced real-life patients in their glycemic and weight-loss goals The multidisciplinary team and patient Endocrinologist: Prof. Dr med. Michael Nauck, Bochum, Germany Primary Care Physician: Dr Kevin Fernando, Berwick, UK Patient Advocate: Ms Kelly Ann Hardy, Margate, UK This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchendocrinologyime.org/mdt-integrating-glp1ras-t2d-management-from-pcp-to-patient/